New York, USA – July 28, 2020 – Microbiosci, the major division of Creative Biogene, has devoted years of efforts in facilitating microbial research with a wide range of high-quality products and services in microbial genome editing, identification, sequencing, proteomics and metabolomics, recently announced the release of its microbial fermentation service in order to accelerate the development of microbial technologies.
The world-class facilities of Micobiosci are equipped with a series of biosafety level 1 (BSL-1) expression systems. Besides, Microbiosci specializes in providing complex downstream processing, formulation, filling/finishing and release testing services, including GMP. With our unparalleled experience, advanced facilities, commitment to quality, innovative nature, and dedicated project management, Microbiosci is capable to help assist fermented products reach their full potential whether it is a small development project or commercial-scale market leadership. Microbiosci’s integrated fermentation and purification development and analytical development teams work together to achieve the highest quality program goals while maintaining flexibility to adapt to program needs.
With the rapid development of genomics, metabolomics and proteomics, microbial fermentation provides great potential for treatment, feed, biological agriculture and bioenergy. Microbiosci has extensive experience in the use of microorganisms to develop and manufacture final formulations and APIs for drugs, pesticides, veterinary drugs and industrial enzymes.
Microbial fermentation services of Microbisci include but not limited to the following:
• Secondary metabolites
• Modified peptide
• Advanced chemicals
“Microbiosci has dedicated field experts, an experienced and flexible expert team that can provide our customers with highly complex fermentation production lines, from basic and detailed engineering design, construction, installation to commissioning,” said Marcia Brady, the marketing director of Creative Biogene, she also added, “As the foundation of the network, Microbiosci provides comprehensive microbial fermentation services to support research, process development, preclinical research and phase I clinical trials. It is fully customizable and can flexibly meet customer requirements for any of the above processes.”
Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.